Update: Horizon Discovery to Offer Partners Precise CRISPR Gene Editing
Update (14/01/20): Horizon Discovery will offer partners access to a precise version of CRISPR gene…
14/01/2020 - 3 minutes
Horizon Discovery
Chasing the Holy Grail of Cell Therapy
Biotech entrepreneur Darrin Disley, ex-CEO and co-founder of the successful Cambridge gene editing biotech Horizon…
01/04/2019 - 7 minutes
CRISPR/Cas9: Could the Gene Editing Technology be the Future of Drug Discovery?
The emergence of CRISPR/Cas9 technologies has enabled almost unlimited gene editing opportunities. Not only could…
06/02/2018 - 9 minutes
Check Out these 42 European SynBio Startups Reimagining the Industry
Synthetic biology, or synbio for short, is rapidly infiltrating multiple fields. From bioplastics to food…
21/06/2017 - 1 minute
You Can Now Search Worldwide Genomic Data in a Single Platform
Access to data is still the main bottleneck for genomic researchers. Repositive has created a…
27/03/2017 - 5 minutes
The Shiniest Golden Vertex? 15 Great Biotechs in Cambridge
Cambridge's image is tied to its Hogwarts-like University and Nobel-hoarding academia, but there's also an…
30/01/2017 - 8 minutes
The UK Steps Up its Game in Automated CRISPR Gene Editing
Horizon Discovery now has full access to CRISPR technology and will develop an automated gene…
16/01/2017 - 2 minutes
€365M deal for a Danish ‘DNA barcode’ Drug Screening Platform
The giant Amgen has offered Nuevolution €365M to develop oncology and neuroscience drugs. The small Danish…
05/10/2016 - 3 minutes
Promising Boston-based CRISPR Startup hits up Horizon to fix Gene Misregulation
An American outfit from Third Rock Ventures, Fulcrum Therapeutics, has made a deal with Horizon to…
07/09/2016 - 2 minutes
New Joint Venture to Shake Up Immuno-Oncology in the UK
Avvinity Therapeutics is the new child of two UK Biotechs: Horizon Discovery and Centauri. The goal?…
02/03/2016 - 3 minutes
The Cambridge Gene-Editing Biotech Success Story: Horizon Discovery is Doubling in Size with new HQ
Horizon Discovery is a gene-editing tools specialist with various biotech partnerships over their cell-line catalogues.…
28/10/2015 - 2 minutes
Rabbit Antibodies proven to be more specific than Mice in Immuno-oncology PD-L1 Research
Abcam is a Cambridge (UK) Biotech who have developed a monoclonal antibody (mAB) production platform…
08/10/2015 - 3 minutes
